Internal Medicine, Hematology & Oncology · Aurora, CO
NPI
1124002456
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1700 S Potomac St
Aurora, CO, 80012
Phone (303) 418-7600
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.5M
135,493 services
Medicare patients, 2024
502
Average age 75
Drug cost, 2024
$2.0M
1,259 prescriptions
Company payments, 2025
$28K
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Douglas M Reznick was code J9271 (injection, pembrolizumab, 1 mg), 13,000 times for 15 patients. In total Douglas M Reznick billed 135,493 services in 180 codes, and Medicare paid $2.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-02-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9271 Injection, pembrolizumab, 1 mg | Office | 13,000 | 15 | $44.60 | $580K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 9,830 | 11 | $2.31 | $23K |
| J1756 Injection, iron sucrose, 1 mg | Office | 7,200 | 17 | $0.17 | $1,210 |
| J1453 Injection, fosaprepitant, 1 mg | Office | 6,150 | 19 | $0.11 | $703 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 3,090 | 35 | $0.10 | $319 |
| J0897 Injection, denosumab, 1 mg | Office | 2,520 | 15 | $19.95 | $50K |
| J1568 Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | Office | 2,110 | 12 | $37.10 | $78K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 1,800 | 17 | $15.73 | $28K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 1,256 | 45 | $0.09 | $111 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 980 | 34 | $0.73 | $718 |
| 85025 Blood Count | Office | 796 | 169 | $7.58 | $6,031 |
| J1626 Injection, granisetron hydrochloride, 100 mcg | Office | 710 | 25 | $0.23 | $166 |
| 36415 Venipuncture Blood Collection | Office | 654 | 166 | $8.65 | $5,657 |
| 80053 Clinical Chemistry | Office | 545 | 138 | $10.35 | $5,641 |
| 83735 Clinical Chemistry | Office | 389 | 94 | $6.57 | $2,556 |
By year: 2022 $2.0M for 153,091 services; 2023 $2.0M for 129,295 services; 2024 $2.5M for 135,493 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 796 | 169 | $7.58 | $6,031 |
| 36415 Venipuncture Blood Collection | 654 | 166 | $8.65 | $5,657 |
| 80053 Clinical Chemistry | 545 | 138 | $10.35 | $5,641 |
| 83735 Clinical Chemistry | 389 | 94 | $6.57 | $2,556 |
| 84443 Clinical Chemistry | 192 | 84 | $16.46 | $3,160 |
| 84439 Clinical Chemistry | 157 | 78 | $8.84 | $1,388 |
| 84100 Clinical Chemistry | 151 | 65 | $4.65 | $702 |
| 83540 Clinical Chemistry | 117 | 58 | $6.34 | $742 |
| 83550 Clinical Chemistry | 117 | 58 | $8.57 | $1,003 |
| 82728 Clinical Chemistry | 116 | 57 | $13.36 | $1,550 |
Medicare prescription drug claims, 2024
In 2024, the drug Douglas M Reznick prescribed most often to Medicare patients was Levothyroxine Sodium, with 126 prescriptions and refills. In total Douglas M Reznick wrote 1,259 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 126 | 285 | 36 | $868 |
| Eliquis Apixaban | 98 | 140 | 24 | $78K |
| Prednisone Generic | 76 | 97 | 27 | $281 |
| Folic Acid Generic | 70 | 171 | 20 | $552 |
| Xarelto Rivaroxaban | 54 | 97 | 13 | $54K |
| Dexamethasone Generic | 53 | 58 | 34 | $1,238 |
| Gabapentin Generic | 43 | 52 | 14 | $468 |
| Liothyronine Sodium Generic | 41 | 68 | Under 11 | $1,116 |
| Warfarin Sodium Generic | 33 | 61 | Under 11 | $232 |
| Prochlorperazine Maleate Generic | 32 | 32 | 20 | $415 |
| Potassium Chloride Generic | 31 | 51 | Under 11 | $295 |
| Levetiracetam Generic | 24 | 28 | Under 11 | $609 |
| Ondansetron Hcl Generic | 22 | 26 | 17 | $272 |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 20 | 20 | 15 | $294 |
| Methylprednisolone Generic | 18 | 18 | Under 11 | $977 |
Brand drugs: 398 claims; generic drugs: 861 claims; opioid claims: 71.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Douglas M Reznick $28K ($28K in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $20K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 14 | $20K |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 9 | $7,396 |
| Ethicon Inc. JNJ | 1 | $146 |
| Monteris Medical Corporation | 1 | $136 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $40.96 |
| Celgene Corporation BMY | 1 | $22.48 |
| Incyte Corporation INCY | 1 | $22.27 |
| Tolmar, Inc. | 1 | $21.06 |
| pharmaand GmbH | 1 | $21.06 |
| Novartis Pharmaceuticals Corporation NVS | 1 | $15.93 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.